A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge Model
Clinical trial NCT03691623 · COMPLETED
Trial details
- NCT number
- NCT03691623
- Sponsor
- Enanta Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-15
- Primary completion
- 2019-09-30
- Enrollment
- 179
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.